Atea Pharmaceuticals, Inc.AVIRNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-192.95M
↓ 251% below average
Average (6y)
$-54.93M
Historical baseline
Range
High:$138.38M
Low:$-192.95M
CAGR
+65.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-192.95M | -17.5% |
| 2023 | $-164.16M | -25.7% |
| 2022 | $-130.65M | -194.4% |
| 2021 | $138.38M | +1354.6% |
| 2020 | $-11.03M | +24.5% |
| 2019 | $-14.61M | -54.1% |
| 2018 | $-9.48M | - |